CRISPRおよびCRISPR関連(Cas)遺伝子の世界市場分析:製品別(ベクター系…DNAフリーCas)、用途別(ゲノム工学、病気モデル、機能ゲノミクス)、エンドユーザー別、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use, And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 CRISPR and Cas Genes Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Rising adoption in diverse fields of biotechnology
3.1.1.1.1 Epigenetics
3.1.1.1.2 Medicine
3.1.1.1.3 Human germline editing
3.1.1.1.4 Tool for qualitative and quantitative plant genome editing
3.1.1.2 Technological advancements in CRISPR technology
3.1.1.3 Introduction of anti-CRISPR protein
3.1.1.4 Ongoing competition for CRISPR commercialization
3.1.2 Market Restraint Analysis
3.1.2.1 Off-target effects of CRISPR technology
3.1.2.2 Intellectual property disputes pertaining to Cas
3.1.2.3 Ethical concerns and implications with respect to human genome editing
3.2 Penetration & Growth Prospect Mapping for Application, 2015
3.3 CRISPR and Cas Genes -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
3.5 CRISPR and Cas Genes Market: Pipeline Analysis
3.5.1 Editas Medicine
3.5.2 Intellia Therapeutics, Inc.
3.5.3 CRISPR THERAPEUTICS
3.5.4 Precision Biosciences
3.5.5 Caribou Biosciences
3.5.6 Cibus
3.5.7 Recombinetics, Inc
3.6 CRISPR and Cas Genes Market: Patent Landscape
Chapter 4 CRISPR and Cas Genes Market: Product Estimates & Trend Analysis
4.1 CRISPR and Cas Genes Market: Product Movement Analysis
4.2 Vector-based Cas
4.2.1 Global vector-based Cas market, 2014 – 2025 (USD Million)
4.3 DNA-free Cas
4.3.1 Global DNA-free Cas market, 2014 – 2025 (USD Million)
Chapter 5 CRISPR and Cas Genes Market: Application Estimates & Trend Analysis
5.1 CRISPR and Cas Genes Market: Application Movement Analysis
5.2 Genome Engineering
5.2.1 Global genome engineering market, 2014 – 2025 (USD Million)
5.3 Disease Models
5.3.1 Global disease models market, 2014 – 2025 (USD Million)
5.4 Functional Genomics
5.4.1 Global functional genomics market, 2014 – 2025 (USD Million)
5.5 Knockdown/Activation
5.5.1 Global knockdown/activation market, 2014 – 2025 (USD Million)
5.6 Others
5.6.1 Global other applications market, 2014 – 2025 (USD Million)
Chapter 6 CRISPR and Cas Genes Market: End-use Estimates & Trend Analysis
6.1 CRISPR and Cas Genes Market: End-use Movement Analysis
6.2 Biotechnology & Pharmaceutical Companies
6.2.1 Global biotechnology & pharmaceutical companies market, 2014 – 2025 (USD Million)
6.3 Academic & Government Research Institutes
6.3.1 Global academic & government research institutes market, 2014 – 2025 (USD Million)
6.4 Contract Research Organizations (CROs)
6.4.1 Global CROs market, 2014 – 2025 (USD Million)
Chapter 7 CRISPR and Cas Genes Market: Regional Estimates & Trend Analysis, by Product, Application, & End-use
7.1 CRISPR and Cas Genes Market Share By Region, 2015 & 2025
7.2 North America
7.2.1 North America CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.3 Europe
7.3.1 Europe CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.3.2 Germany
7.3.2.1 Germany CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.3.3 UK
7.3.3.1 UK CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.4.3 China
7.4.3.1 China CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 Middle East & Africa CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa CRISPR and Cas genes market, 2014 – 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Addgene
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 AstraZeneca
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 Bio-Rad Laboratories, Inc
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 Caribou Biosciences, Inc
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Cellectis
8.3.5.1 Company overview
8.3.5.1.1 Calyxt
8.3.5.2 Financial performance
8.3.5.2.1 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Cibus
8.3.6.1 Company overview
8.3.6.1.1 Nucelis
8.3.6.2 Financial performance
8.3.6.2.1 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 CRISPR THERAPEUTICS
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Editas Medicine
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Egenesis Inc.
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.10 GE Healthcare Dharmacon Inc.
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 GenScript
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives
8.3.12 Horizon Discovery Group plc
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic initiatives
8.3.13 Integrated DNA Technologies, Inc.
8.3.13.1 Company overview
8.3.13.2 Financial performance
8.3.13.3 Product benchmarking
8.3.14 Intellia Therapeutics, Inc.
8.3.14.1 Company overview
8.3.14.2 Financial performance
8.3.14.3 Product benchmarking
8.3.14.4 Strategic initiatives
8.3.15 Lonza
8.3.15.1 Company overview
8.3.15.2 Financial performance
8.3.15.3 Product benchmarking
8.3.15.4 Strategic initiatives
8.3.16 Merck KGaA
8.3.16.1 Company overview
8.3.16.1.1 Sigma-Aldrich Co. LLC
8.3.16.2 Financial performance
8.3.16.2.1 Financial performance
8.3.16.3 Product benchmarking
8.3.16.4 Strategic initiatives
8.3.17 Mirus Bio LLC
8.3.17.1 Company overview
8.3.17.2 Financial performance
8.3.17.3 Product benchmarking
8.3.17.4 Strategic initiatives
8.3.18 New England Biolabs
8.3.18.1 Company overview
8.3.18.2 Financial performance
8.3.18.3 Product benchmarking
8.3.18.4 Strategic initiatives
8.3.19 OriGene Technologies, Inc.
8.3.19.1 Company overview
8.3.19.2 Financial performance
8.3.19.3 Product benchmarking
8.3.19.4 Strategic initiatives
8.3.20 Recombinetics, Inc.
8.3.20.1 Company overview
8.3.20.2 Financial performance
8.3.20.3 Product benchmarking
8.3.20.4 Strategic initiatives
8.3.21 Takara Bio USA
8.3.21.1 Company overview
8.3.21.2 Financial performance
8.3.21.3 Product benchmarking
8.3.21.4 Strategic initiatives
8.3.22 Thermo Fisher Scientific, Inc.
8.3.22.1 Company overview
8.3.22.2 Financial performance
8.3.22.3 Product benchmarking
8.3.22.4 Strategic initiatives
8.3.23 Transposagen Biopharmaceuticals, Inc.
8.3.23.1 Company overview
8.3.23.2 Financial performance
8.3.23.3 Product benchmarking
8.3.23.4 Strategic initiatives


【レポート販売概要】

■ タイトル:CRISPRおよびCRISPR関連(Cas)遺伝子の世界市場分析:製品別(ベクター系…DNAフリーCas)、用途別(ゲノム工学、病気モデル、機能ゲノミクス)、エンドユーザー別、セグメント予測、2014-2025
■ 英文:CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use, And Segment Forecasts, 2014-2025
■ 発行日:2017年1月31日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707227
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。